Scholars Central

Conference abstractPublished 23 Jul 2018

Optimizing the management of advanced ovarian malignancy using cytoreductive surgery plus regional and systemic chemotherapy

Authors: Paul H Sugarbaker

Washington Cancer Institute, Washington, USA; Peritoneal Surface Oncology Group International, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: Ovarian cancer presents in a majority of patients with cancer dissemination widely distributed on the peritoneal surfaces of the abdomen and pelvis. In a substantial proportion of patient’s not only peritoneal metastases but also lymph nodal metastases will be present at the time of diagnosis. Methods: The procedures required for complete surgical removal of all clinical evidence of ovarian cancer is pursued using complete cytoreductive surgery (CRS). This may be performed either before or after neoadjuvant systemic chemotherapy. At the time of surgery hyperthermic intraperitoneal chemotherapy (HIPEC) is used to improve the control of peritoneal metastases. As the patient recovers from CRS plus HIPEC, combined intraperitoneal and systemic chemotherapy are initiated for a six month interval. Results: Cytoreductive surgery is associated with marked improvement in survival especially when all visible evidence of disease is removed. In addition, HIPEC has been shown in randomized controlled trials to improve survival, primarily by limiting the recurrence of peritoneal metastases. Also, long-term normothermic intraperitoneal chemotherapy (NIPEC-LT) combined with systemic chemotherapy has been shown in randomized trials to show significant benefits. Conclusions: Combinations of complete CRS, HIPEC combined in the operating room with CRS and then NIPEC-LT plus systemic chemotherapy will optimize the long-term survival of patients with advanced ovarian malignancy. The clinical evidence for these benefits can be organized into an evidence-based treatment plan for this disease.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Gynecology & Obstetrics.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalGynecology & Obstetrics
  • SubjectReproductive Medicine & Gynaecology
  • BylineArticles whose byline prints “Paul H Sugarbaker”